A 40 minute test could reduce the risk of a second stroke. Manchester researchers and Genedrive plc have developed a new rapid genetic test to identify gene mutations that could reduce the effectiveness of a drug commonly prescribed to people who have had an ischaemic stroke. #BritishHeartWeek
— Faculty of Biology, Medicine and Health (@fbmh-uom.bsky.social) 2025-06-10T13:35:15.159Z
Share this:
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on WhatsApp (Opens in new window) WhatsApp
- Click to print (Opens in new window) Print
- Click to email a link to a friend (Opens in new window) Email
- More
msamba 